Grace Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$4.42

+0.04 (+0.91%)

As of Mar 22, 10:47 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +422.4% upside

Low Target $18.68

Average Target $23.09

High Target $33.94

Current Price $4.42

Current
$4.42

Target
$23.09

$18.68 $23.09 avg $33.94

Scenario Analysis

Bear Case

$18.68

322.6%

Low target

Base Case

$23.09

+422.4%

Avg target

Bull Case

$33.94

+667.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$4.71

-6.2% from high

52-Week Low

$1.75

+152.6% from low

Target vs 52W High

$23.09

+389.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%